Timing is Everything

[stevo51]

ATNM: ATNM ++$31 price target ---new report from Agora Financial Recommendation: Buy Actinium Pharmaceuticals (NYSE:ATNM) up to $7.00 Actinium’s current clinical pipeline has a potential value of several billion dollars in annual sales. It also has an important shareholder Phillip Frost. I can easily see shares shooting as high as $31, which would mean a nearly 1,150% gain from current